Press releaseBusiness Wire
Kestra Medical Technologies
KMTS · NASDAQ
$28.28−$1.09 (−3.71%)TodayMarket closed ·
Prev close $29.37
Latest news
- NewsAvi Kapoor
Kestra Medical Technologies Posts Mixed Q1 Results, Joins Enova International, Dave and Buster's And Other Big Stocks Moving Lower In Tuesday’s Pre-Market Session
- News
Transcript: Kestra Medical Techs Q1 2027 Earnings Conference Call
- News
12 Health Care Stocks Moving In Monday's After-Market Session
- Press releaseGlobe Newswire
Kestra Medical Technologies Reports First Quarter Fiscal 2027 Financial Results
- NewsAvi Kapoor
Kestra Likely To Report Q1 Loss; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call
- Press releaseGlobe Newswire
Kestra Names Daniel Finney Vice President of Research & Development
- News
12 Health Care Stocks Moving In Tuesday's After-Market Session
- Press releaseGlobe Newswire
Kestra Medical Technologies Secures Up to $200 Million of Non-Dilutive Financing
- Press releaseGlobe Newswire
Kestra Medical Technologies Reports Fourth Quarter and Fiscal Year 2026 Financial Results
- News
Earnings Scheduled For July 14, 2026
- Press releaseGlobe Newswire
Kestra Showcases Accelerated Innovation at HRS 2026
- News
12 Health Care Stocks Moving In Tuesday's After-Market Session
- Press releaseGlobe Newswire
Kestra Medical Technologies Reports Third Quarter Fiscal 2026 Financial Results
- News
Earnings Scheduled For March 17, 2026
- Press releaseGlobe Newswire
Kestra Medical Technologies Announces Strategic Collaboration with Biobeat Technologies to Expand Diagnostic Insight for Wearable Defibrillator Patients During Cardiac Recovery
- News
12 Health Care Stocks Moving In Thursday's After-Market Session
- Press releaseGlobe Newswire
Kestra Medical Technologies Reports Second Quarter Fiscal 2026 Financial Results
- News
Earnings Scheduled For December 11, 2025
- Press releaseGlobe Newswire
Kestra Medical Technologies Reports Preliminary Second Quarter Fiscal 2026 Financial Results
- NewsAvi Kapoor
This Lumentum Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday
- Press releaseGlobe Newswire
Largest Real-World Study of Wearable Defibrillators Confirms Strong Effectiveness and Safety Performance of Kestra's ASSURE Device
- Press releaseGlobe Newswire
Kestra Medical Technologies Reports First Quarter Fiscal 2026 Financial Results
- Press releaseBusiness Wire
Biobeat Technologies Names Raymond W. Cohen as Chairman of the Board of Directors
- Press releaseBusiness Wire
Omega Funds Closes Oversubscribed $647 Million Fund VIII to Invest in Transformative Life Science Companies
- Press releaseGlobe Newswire
Kestra Medical Technologies Wins 2025 Top Workplaces Industry Award, A National Recognition
- Press releaseGlobe Newswire
Kestra Medical Technologies Reports Fourth Quarter and Fiscal Year 2025 Financial Results
- Press releasePRNewswire
Archimedes Vascular Announces Close of Series A Financing led by Sherpa Healthcare Partners and Appoints Raymond W. Cohen as Chairman of its Board of Directors
- Press releaseGlobe Newswire
Kestra Medical Technologies Reports Third Quarter Fiscal 2025 Financial Results
- Press releaseBusiness Wire
Nalu Medical Appoints Veteran Medtech Executive Raymond W. Cohen Chairman of its Board of Directors
- NewsAvi Kapoor
This Norwegian Cruise Line Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.